A 59-year-old man presented with progressive hoarseness and dyspnea over a 2-month period. Fifteen months previously, he had undergone allogeneic stem cell transplant (allo-SCT) with a matched related donor for treatment of fms-like tyrosine kinase (FLT3) internal tandem duplication–mutated acute myeloid leukemia (AML). The patient had been diagnosed with chronic gastrointestinal graft-vs-host disease after a workup for diarrhea. Results of a restaging bone marrow biopsy 2 weeks prior to presentation showed no evidence of leukemia. Physical examination findings revealed no neck masses or abnormalities, but the patient was noted to be severely dysphonic and stridulous. Flexible laryngoscopy findings demonstrated a right vocal fold neoplasm crossing the posterior commissure with associated bilateral vocal fold motion impairment and obstruction of the glottic airway (Figure, A). Awake tracheostomy was performed for airway protection, and biopsy of the neoplasm was obtained via operative microlaryngoscopy (Figure, B). Histologic findings demonstrated diffuse infiltrate of large cells with irregular nuclear contours, vesicular chromatin, and prominent nucleoli (Figure, C). Immunohistochemical stains showed CD33, CD43, and CD117 positivity, with a subset positive for CD7 and myeloperoxidase. Stains were negative for CD3, CD20, and cytokeratin expression.
McMichael B, Foucar CE, Morrison RJ. Hoarseness and Stridor Following Stem Cell Transplant. JAMA Otolaryngol Head Neck Surg. 2021;147(11):1003–1004. doi:10.1001/jamaoto.2021.2448
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.